Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

Ebola Paper Demonstrates Disease Transmission Rate

by Global Biodefense Staff
September 12, 2014
Ebola Virus Outbreak

Scanning electron micrograph of Ebola virus budding from the surface of a Vero cell (African green monkey kidney epithelial cell line. Credit: NIAID

New research from Arizona State University and the University of Tokyo that analyzes transmission rates of Ebola in West African countries shows how rapidly the disease is spreading.

Researchers Gerardo Chowell-Puente, ASU School of Human Evolution and Social Change Associate Professor, and Hiroshi Nishiura of the University of Tokyo found that transmission rates for each single case of Ebola consistently showed at least one new case of the disease being transmitted. Country-specific analysis of transmission rates in Liberia and Sierra Leone showed on average between one and two new cases for every existing case.

“Our analysis of the reproduction numbers of Ebola cases shows continuous growth from June to August 2014 that signalled a major epidemic,” Nishiura said. “Uncontrolled cross-border transmission could fuel a major epidemic to take off in new geographical areas as was seen in Liberia.”

Rates of transmission increased from June to July in Sierra Leone and Liberia from 1.4 to 1.7 respectively for every existing case. The statistical analysis is detailed in the paper, “Early transmission dynamics of Ebola virus disease, West Africa, March to August 2014,” published today in Eurosurveillance.

“Our findings suggest that control of the Ebola epidemic that has taken so many lives could be attained by preventing more than half of the secondary transmissions for each primary case. This could be attained by isolating those with Ebola and tracing each case to its source,” Chowell said.

The current epidemic is the largest and first regional outbreak of Ebola in Africa. The outbreak was not recognized until March of 2014 after starting around December of 2013, which facilitated the spread to Sierra Leone, Liberia and Nigeria. The World Health Organization declared the epidemic a Public Health Emergency of International Concern in August.

“Characterizing the distribution of secondary cases from a single case can help healthcare workers and officials understand Ebola transmission dynamics over time in affected countries and gauge the effect of interventions to control spread of the disease,” he added.

Researchers analyzed case counts by the World Health Organization as of Aug. 26, 2014. Two groups of data were used: confirmed and probable cases; and the total number of reported cases (confirmed, probable and suspected cases).

Transmission rates are consistent with the rate of spread from prior outbreaks in Central Africa, researchers found.

“Close monitoring of this evolving epidemic should continue in order to assess the status of the outbreak in real time and guide control interventions in the region,” Chowell said.

Source: Arizona State University

Tags: EbolaEmerging Threats

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Bat Virus Receptor Studies Vital to Predict Spillover Risk
Pathogens

Bat Virus Receptor Studies Vital to Predict Spillover Risk

December 7, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC